줄기세포 치료 시장 규모, 점유율, 성장 분석 : 세포원별, 유형별, 치료 용도별, 지역별 - 산업 예측(2025-2032년)
Stem Cell Therapy Market Size, Share, and Growth Analysis, By Cell Source (Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells), By Type, By Therapeutic Application, By Region - Industry Forecast 2025-2032
상품코드:1690010
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 줄기세포 치료 시장 규모는 2023년에 123억 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 14.3%로, 2024년 140억 6,000만 달러에서 2032년에는 409억 6,000만 달러로 성장할 전망입니다.
세계 줄기세포 치료 시장은 암과 같은 질병의 유병률 증가와 재생의료의 발전에 힘입어 크게 성장하고 있습니다. 줄기세포는 치유와 조직 재생을 돕는 특수 세포를 개발할 수 있는 만능 공급원 역할을 하며, 줄기세포 치료를 기존 장기 이식에 대한 대안으로 자리 매김하고 있습니다. 연구자들은 줄기세포를 혁신적으로 배양하고 변형하여 심근이나 혈액 세포와 같은 특정 세포를 생성하여 치료 옵션을 늘리고 있습니다. 또한 성체 조직에서 유도된 유도만능줄기세포의 잠재력이 시장을 지원하고 있으며, 치료의 새로운 길을 열어줄 것으로 기대되고 있습니다. 또한 줄기세포 이식과 같이 손상된 세포를 대체하는 치료법은 혈액 관련 질환 및 악성 종양 치료법을 크게 변화시키고 있으며, 시장의 큰 잠재력을 부각시키고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
특허 분석
기술 분석
사례 연구
줄기세포 치료 시장 규모 : 세포원별 & CAGR(2025-2032)
시장 개요
지방조직 유래 중간엽줄기세포
골수 유래 중간엽줄기세포
태반/제대 유래 중간엽줄기세포
기타
줄기세포 치료 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
동종이계 줄기세포 치료
자가 줄기세포 치료
줄기세포 치료 시장 규모 : 치료 용도별 & CAGR(2025-2032)
시장 개요
근골격 장애
상처와 수술
염증성 질환과 자가면역질환
재생의료
의약품 발견과 개발
심혈관질환
신경질환
기타
줄기세포 치료 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Novartis AG(Switzerland)
Pfizer Inc.(US)
Mesoblast Limited(Australia)
Gamida Cell Ltd.(Israel)
Vericel Corporation(US)
Medipost Co., Ltd.(South Korea)
Astellas Pharma Inc.(Japan)
Cynata Therapeutics Limited(Australia)
Lonza Group Ltd.(Switzerland)
Caladrius Biosciences, Inc.(US)
Athersys, Inc.(US)
Cytori Therapeutics, Inc.(US)
Holostem Terapie Avanzate S.r.l.(Italy)
Pluristem Therapeutics Inc.(Israel)
BioTime, Inc.(US)
Smith+Nephew(UK)
JCR Pharmaceuticals Co., Ltd.(Japan)
Anterogen Co., Ltd.(South Korea)
Corestem, Inc.(South Korea)
Pharmicell Co., Ltd(South Korea)
결론과 제안
KSA
영문 목차
영문목차
Global Stem Cell Therapy Market size was valued at USD 12.3 billion in 2023 and is poised to grow from USD 14.06 billion in 2024 to USD 40.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).
The global stem cell therapy market is witnessing significant growth, driven by the increasing prevalence of diseases such as cancer and advancements in regenerative medicine. Stem cells serve as a versatile source for developing specialized cells to aid in healing and tissue regeneration, positioning stem cell therapy as a viable alternative to traditional organ transplantation. Researchers are innovatively cultivating and modifying stem cells to create specific cell types, such as heart muscle or blood cells, enhancing treatment options. The market is further supported by the potential of induced pluripotent stem cells derived from adult tissue, promising new avenues in therapy. Additionally, procedures like stem cell transplants, which replace damaged cells, are transforming how blood-related disorders and malignancies are treated, highlighting immense market potential.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Stem Cell Therapy Market Segments Analysis
Global Stem Cell Therapy Market is segmented by Cell Source, Type, Therapeutic Application and region. Based on Cell Source, the market is segmented into Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells, Placenta/Umbilical Cord-derived Mesenchymal Stem Cells and Other. Based on Type, the market is segmented into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. Based on Therapeutic Application, the market is segmented into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Regenerative Medicine, Drug Discovery and Development, Cardiovascular Diseases, Neurological Disorders and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Stem Cell Therapy Market
The Global Stem Cell Therapy market is significantly driven by financial support from government agencies and favorable regulatory frameworks that create a supportive environment for research and development in this field. The growing demand for innovative and effective treatment alternatives for autoimmune, neurological, and cardiovascular disorders has led to heightened research initiatives and increased funding for cell-based studies. This emphasis on advancing therapeutic solutions fosters a robust landscape for stem cell research, ultimately enhancing the potential for breakthroughs and improvements in patient care, thus propelling the expansion of the stem cell therapy market on a global scale.
Restraints in the Global Stem Cell Therapy Market
The global stem cell therapy market faces significant challenges primarily due to ethical concerns surrounding the use of embryonic stem cells. These cells are predominantly sourced from human embryos, raising moral issues related to the potential destruction of human life. This ethical dilemma complicates the commercial development of stem cell treatments. Furthermore, the landscape for stem cell research and applications is inconsistent across different regions, influenced by varying regulations and public perceptions. As a result, these factors create a complex environment that hinders advancements and acceptance within the stem cell therapy market.
Market Trends of the Global Stem Cell Therapy Market
The Global Stem Cell Therapy market is witnessing significant growth and transformation, driven by advancements in therapeutic innovations and increased demand for regenerative medicine. Pharmaceutical companies are actively seeking specialized talent with expertise in stem cell research and product development, reflecting a shift towards more complex therapeutic applications. As they explore novel drug delivery systems and expand their product portfolios, collaboration with firms possessing deep knowledge in biological sciences and controlled release methodologies has become paramount. This trend highlights the burgeoning intersection of research and commercialization in stem cell therapies, paving the way for breakthrough treatments and improved patient outcomes in the healthcare sector.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Technology Analysis
Case Studies
Global Stem Cell Therapy Market Size by Cell Source & CAGR (2025-2032)
